To characterize the exosomal proteins of T-cell-derived exosomes from SLE patients, CD9+ or CD63+exosomes derived from T cells of SLE patients and healthy controls (HCs) were subjected to mass spectrometry-based proteomics (Table 1). This evidence concerns the gene CD63 and systemic lupus erythematosus.